Abbott’s Mark Kontny joins Patheon

May 6, 2010
Manufacturing and Production Patheon, appointment, manufacturing and production

Patheon has appointed Dr Mark Kontny president of global pharmaceutical development services and chief scientific officer. He joins the contract …

Pfizer and Merck post modest results

May 6, 2010
Sales and Marketing 2010 financials, Merck, Pfizer

The acquisition of Wyeth has added over $5 billion to Pfizer’s revenue buts its own sales fail to shine.  Both …

Greece’s crisis could hit European prices

May 6, 2010
Sales and Marketing Greece, industry, parallel trade, prices

GlaxoSmithKline’s chief executive Andrew Witty has warned that the economic crisis in Greece could have a knock-on effect across Europe, …

Sanofi signs Indian pain drug development deal

May 5, 2010
Research and Development Glenmark, Sanofi-Aventis, chronic pain, pain therapeutics

Sanofi-Aventis has signed an agreement with Indian firm Glenmark Pharmaceuticals to develop novel agents for the treatment of chronic pain. …

Collaborative cancer drug project targets research efficiency

May 5, 2010
Research and Development Animal testing, Animal tests, Cancer, biomarkers, clinical drug development

A new pharma-academia project being managed by the University of Dundee is setting its sights on improving the effectiveness of …

Blog footer

Digital Pharma: Online medical information influences treatment

May 5, 2010
Medical Communications, Sales and Marketing Datapharm, digital patients, patient information

More than half of health searches in the UK result in treatment or management changes, according to new research by …

Virgo expands med ed team

May 5, 2010
Medical Communications Virgo, appointment, medical communications

Virgo Health has expanded its medical education offering, appointing Katherine Mantell and Adam Pittard. Katherine joins the agency as editorial …

More quality issues dog J&J

May 5, 2010
Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls

Johnson & Johnson’s manufacturing is under the spotlight at the FDA once again for quality issues affecting its products. At …

Oxford BioMedica hopes vaccine first will raise interest

May 5, 2010
Sales and Marketing Dendreon, Oxford BioMedica, Provenge, TroVax

Oxford BioMedica is hoping that the approval of the world’s first immunotherapy cancer vaccine in the US will help it …

BMS on tenterhooks over belatacept future

May 4, 2010
Research and Development BMS, belatacept

Bristol-Myers Squibb has been kept on tenterhooks by US regulator the FDA over the future of its investigational kidney transplant …

Pfizer still at number 1, but Lipitor to slip

May 4, 2010
Sales and Marketing Humira, Lipitor, Pfizer, sales

New research suggests that the pharma world is going to be shaken up over the next few years – although …

Laurence_Debroux

Sanofi’s chief strategic officer to step down

May 4, 2010
Sales and Marketing Sanofi-Aventis, appointment, sales and marketing

Laurence Debroux, chief strategic officer at Sanofi-Aventis, is to leave the company at the end of June. The company said …

Chiltern Wins Award at the Inaugural US Pharma Awards Ceremony

May 4, 2010
Research and Development

Glenn Kerkhof, Chiltern CEO, congratulated Kim Todd, Chiltern’s Silver Medal Award Winner in the category of experienced Clinical Research Associate/Site …

EU votes for tighter internet drug regulations

May 4, 2010
Sales and Marketing EU, counterfeits, viagra

The European Parliament has voted to enact stronger legislation against poor quality medicines available on the internet. The move comes …

Staff cuts already planned, warns nurses’ leader

May 4, 2010
NHS trusts, election, general election, nurses

The leader of nurses in the UK has warned that NHS trusts around the country are already planning significant job …

Contract research news in brief

May 4, 2010
Research and Development Corealis, Norwich Pharma, PPD, PRA, biofocus

Our round-up of developments in the contract research sector includes a new $41m contract for BioFocus, new locations for PPD, …

Evotec wins grant to advance H3 receptor antagonist

May 4, 2010
Research and Development CNS, Evotec, MS

Evotec is to receive funding of up to 1.5 million euros from a German government fund to advance its H3 …

Enlacamacomonunca.com

Digital Pharma: Bayer expands InBed ED campaign

April 30, 2010
Medical Communications Bayer Schering Pharma, digital pharma, disease awareness campaigns, erectile dysfunction

Bayer Schering Pharma has launched a Spanish version of its InBed erectile dysfunction disease awareness campaign. Under the tagline ‘en la …

Colorcon buys French excipients specialist

April 30, 2010
Manufacturing and Production Colorcon, Ethypharm, NP Pharm, contract manufacturing, excipients

US-based Colorcon has acquired excipient specialist NP Pharm, a division of French drugmaker Ethypharm, in order to expand its product portfolio …

Shire revenue dips after generic Adderall hit

April 30, 2010
Sales and Marketing Adderall, Fabrazyme, Gaucher's, Shire

Shire’s first quarter revenues fell by 5% after its ADHD treatment Adderall XR succumbed to generic competition from Teva.  This …

The Gateway to Local Adoption Series

Latest content